Australia Coronavirus vaccine advice on AstraZeneca has changed again — here's what it means for under-60s

23:26  17 june  2021
23:26  17 june  2021 Source:   abc.net.au

Aussies more likely to die in crashes and Covid than from AZ vaccine

  Aussies more likely to die in crashes and Covid than from AZ vaccine The British-made jab is all but banned in Australia for anyone under 50 after a handful of cases, only one of which was fatal, but the chance of developing a blood clot from the vaccine is just 0.0005 per cent.The British-made jab is all but banned in Australia for anyone under 50 after a handful of cases, only one of which was fatal.

The Pfizer vaccine is now the preferred coronavirus jab for Australians under 60, after medical experts re-assessed the risks posed by the AstraZeneca inoculation.

The Australian government says the new advice balances the risk of developing a rare blood clotting condition after getting the vaccine against the effects of COVID-19.

But why has that risk changed, why is blood clotting a risk in younger people, and should you be alarmed if you've already had the vaccine?

Here's what we know.

What's the background to the changed advice?

The AstraZeneca vaccine was linked to a rare blood clotting condition known as TTS, or thrombosis and thrombocytopenia syndrome, earlier this year.

Experts want age limit for AstraZeneca COVID-19 vaccine reviewed after latest death

  Experts want age limit for AstraZeneca COVID-19 vaccine reviewed after latest death Some researchers and medical specialists are calling for a review of the age groups who receive the AstraZeneca jab, after a 52-year-old woman died from a brain clot last week. "It may be time to consider now that we do offer Pfizer vaccine for the 50 to 59-year-old age group," said associate professor Margie Danchin, a clinician who researches vaccine risk perception.Dr Danchin wants to see the age cut-off for AstraZeneca reviewed after the latest death from a condition known as thrombosis with thrombocytopenia syndrome (TTS).

It is extremely rare — in the UK about 14 people per 1 million have developed it after their first dose.

Back in April, the panel of experts that advises the federal government on vaccines, ATAGI, recommended that Pfizer become the preferred vaccine for under-50s due to the increased risk of TTS in younger people.

But in the past week, seven out of 12 people in Australia who developed TTS after the AstraZeneca vaccine were in the 50-59 age group.

"That has changed the rate of that particular issue within that age group to the point where the rate is very similar to the under-50s," Chief Medical Officer Paul Kelly said.

"And so that's been the key new information that has gone to ATAGI and they've based that on the risk-benefit equation, now being the risk outweighing the benefit in that particular age group," Professor Kelly said.

AstraZeneca and Pfizer COVID vaccine shots lead to missed work days, survey reveals

  AstraZeneca and Pfizer COVID vaccine shots lead to missed work days, survey reveals It's normal to have some side effects after the COVID vaccine, but new research shows people report more symptoms after the first AstraZeneca vaccine and second Pfizer dose. Here's what to expect."I get my flu shot every year and don't normally get any reaction at all," Mr Cronin said.

The ABC understands some of the seven new TTS cases in that age group are severely ill, but a number of them have less severe illness.

Why does blood clotting from the AstraZeneca jab mostly affect younger people?

The answer to why this rare condition occurs in younger people is still being investigated.

"We don't exactly know why it's more common in younger people … than it is in older people," Kristine Macartney, the director of the National Centre for Immunisation Research and Surveillance, said.

"It may be something to do with the very strong immune response that they experience to AstraZeneca vaccines.

"But it is so rare that, to date, it hasn't been possible to identify any predictive factors."

Professor Kelly has also previously said it was most likely a result of the immune system responding to the adenovirus contained in the AstraZeneca vaccine.

"Younger people, we know, have a more robust immune system and are likely to have this sort of reaction," he said in April.

Second AstraZeneca dose 'absolutely critical' despite change to age advice

  Second AstraZeneca dose 'absolutely critical' despite change to age advice Officials say it is "absolutely critical" that Australians follow through with their second AstraZeneca jab, despite the cut off age being raised yesterday.Health Minister Greg Hunt and Australian Medical Association (AMA) President Dr Omar Khorshid both repeated the plea this morning, advising Aussies the jab is safe and effective.

What do know now that we didn't know when we were saying it was safe from age 50?

We haven't really learned something new — it's all about the risk assessment.

Every week for the past few months, ATAGI has reviewed the rate of TTS cases connected to the AstraZeneca vaccine.

Back in April, the expert group advised that the Pfizer vaccine be preferred over the AstraZeneca jab in people under 50.

But that recommendation was always subject to change, if the rates of the rare TTS condition changed over time.

"What's happened over a number of weeks is that the [rate per 100,000] cases in people aged 50 to 59 years has slowly climbed over time," Professor Macartney said.

"It's also turned out that some of these cases have been quite severe.

"So we really wanted to review the benefits and risks of vaccines in this age group, and are suggesting that it's preferential for people aged 50 to 59 to have a Pfizer rather than an AstraZeneca."

The new cases last week pushed the rate of reported TTS cases in the 50 to 59 age group from 1.9 to 2.7 per 100,000 AstraZeneca doses.

How do Australia's rules compare to overseas?

The rules surrounding AstraZeneca vary from country to country.

Rise in rare clotting cases drove ‘difficult' call on AstraZeneca vaccine

  Rise in rare clotting cases drove ‘difficult' call on AstraZeneca vaccine Concern about a rising number of non-fatal instances of a rare clotting disorder in Australians in their 50s led to the "difficult" decision to limit the AstraZeneca vaccine to those over 60.The federal Health Minister's top immunisation advisers say the decision to limit the AstraZeneca vaccine to over-60s was made because of the concerning number and severity of non-fatal cases of a blood clotting condition in people in their 50s and came after weeks of difficult deliberations.

Federal Health Minister Greg Hunt said Australia's new advice took into account the low level of COVID-19 in Australia.

"We recognise that this is a conservative position, but relative to Australia's risk of having COVID," he said.

"The United Kingdom, for example, has an age range of 40 and above for AstraZeneca, South Korea 30 and above for AstraZeneca, and Germany has no age limits on AstraZeneca for the general product for 18 and above."

Some countries have no age limit on AstraZeneca.

What should I do if I'm over 60?

You should talk to your GP if you have any specific concerns.

But Professor Kelly said AstraZeneca remained a very effective vaccine, and encouraged eligible people to get it.

"The benefit of AstraZeneca in the over 60s remains much higher than the risk of this particularly rare but sometimes serious syndrome [TTS]," he said.

"And so people over 60 should still be rolling out to their GP or wherever they are getting their AstraZeneca vaccine and getting that first dose."

Is it safe to have a second dose of AstraZeneca if I've already had the first?

Experts say yes, it is safe.

If you've already had your first dose of AstraZeneca and had no complications, the official advice says you should get the same vaccine for your second dose.

"Anyone who has had a first dose of AstraZeneca without a problem should feel very confident to have their second dose and should keep that booking," Professor Kelly said.

Fears AstraZeneca reputation has been ‘tarnished' beyond repair

  Fears AstraZeneca reputation has been ‘tarnished' beyond repair Vaccine experts say the negative public sentiment is unfair, and the AstraZeneca jab could be the key to avoiding death and serious illness in Australia this year.Vaccination experts say they fear the reputation of the AstraZeneca vaccine could have been tarnished beyond repair in Australia, leaving the population dangerously exposed to coronavirus outbreaks in the months to come.

Data from the United Kingdom — which has administered far more vaccines than Australia — shows having an adverse reaction to a second dose of AstraZeneca is extremely rare.

The rate of developing TTS after a second AstraZeneca dose is just 1.5 per 1 million, according to a recent update from the UK government.

Professor Kelly said medical experts were well aware of the side effects and what action needed to be taken if patients developed the rare clotting disorder.

"I will be writing again today to all medical practitioners reminding them about the importance of watching and what they need to do, where they need to go to get the most up-to-date advice," he said.

How concerned should I be about the risk of blood clots from AstraZeneca?

Hearing about adverse side effects from vaccines can be concerning, and it's normal to be a bit worried about what it means for you.

However, Professor Kelly stressed that although TTS could be serious, it was very rare, and the medical community had a good understanding of how to diagnose and treat it.

If TTS is suspected, doctors investigate platelet counts, clotting factors and run special immune and antibody tests, as well as imaging studies to determine the site and size of any potential clots.

According to the Melbourne Vaccine Education Centre, patients would likely be treated by a specialist haematologist.

The president of the Australian Medical Association, Omar Khorshid, said: "People who have had the AstraZeneca vaccine should not be alarmed by this decision."

"The risks of serious complications, including clotting, from the AstraZeneca vaccine are very low and Australia is now very good at detecting clots in patients who've had the AstraZeneca vaccine," Dr Khorshid said in a statement.

"More importantly, we have developed very effective protocols and treatments that mean most people fully recover from these complications."

[Zendesk COVID form embed]

People are finding ways to get a COVID-19 vaccine before they're eligible. Here's where Victoria's rules stand .
Oakley Germech was frustrated AstraZeneca vaccine doses allocated for older Australians were going unused, so the 24 year old jumped the queue. Here's what you need to know about vaccine eligibility.He saw reports of a Melbourne clinic allowing any adult to receive the AstraZeneca vaccine with a signed consent form in an apparent breach of national and Victorian rules.

usr: 0
This is interesting!